Given METTL3’s role in mRNA stability, translation, and synaptic plasticity, its downregulation in the striatum may contribute to the dysregulation of the dopaminergic system, an essential component in the development of opioid addiction and withdrawal syndrome [57,59,60]. Here, METTL3 is linked to substance withdrawal syndrome.